Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
US9254309B2 · kind B2 · utility
0Cited by
15References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 2013 |
| Grant date | Feb 9, 2016 |
| Priority date | — |
| Expiry date | Sep 23, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating disorders involving deregulation of cell proliferation and/or angiogenesis comprising the administration of an effective amount of a multivalent synthetic compound comprising a support on which at least 3 pseudopeptide units are grafted, said compound being of formula (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.